Select Medical extends $530M revolver maturity to 2025 via Amendment No. 6

SELECT MEDICAL HOLDINGS CORP

Extends maturity on $530M of $650M revolving facility to March 6, 2025 (or Jan 3, 2025 if term loan not refinanced).
Remaining $120M of revolver commitments continue to mature on March 6, 2024.
Amendment No. 6 entered Feb 21, 2023 with JPMorgan Chase as administrative agent.
Upfront fee of 0.10% of aggregate revolving commitments paid to each revolving lender.
Borrower represented no Event of Default or Default continuing as of effective date.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

SELECT MEDICAL HOLDINGS CORP amended Amendment No. 6 to the Select Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (effective 2023-02-21).

Action: amendment
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
Effective: 2023-02-21

Exact text from the filing

On February 21, 2023, Select Medical Corporation (“ Select ”) and Select Medical Holdings Corporation (“ Holdings ”) entered into Amendment No. 6 (the “ Select Amendment ”) to that certain Credit Agreement, dated as of March 6, 2017, by and among Holdings, Select, the lenders and issuing banks party thereto from time to time and JPMorgan Chase Bank, N.A. (“ JPMorgan ”), as administrative agent and collateral agent (as amended by Amendment No. 1, dated as of March 22, 2018, Amendment No. 2 dated as of October 26, 2018, Amendment No. 3, dated as of August 1, 2019, Amendment No. 4, dated as of December 10, 2019, Amendment No. 5, dated as of June 2, 2021 and the Select Amendment, the “ Select Credit Agreement ”).

View on SEC.gov

Browse all material agreements →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-024295

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.